State Street Corp decreased its position in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 4.8% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 6,505,345 shares of the company’s stock after selling 329,170 shares during the period. State Street Corp’s holdings in Perrigo were worth $170,635,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of PRGO. Venturi Wealth Management LLC acquired a new stake in shares of Perrigo in the third quarter valued at approximately $56,000. KBC Group NV increased its holdings in shares of Perrigo by 25.1% in the third quarter. KBC Group NV now owns 4,517 shares of the company’s stock valued at $118,000 after purchasing an additional 905 shares in the last quarter. Voisard Asset Management Group Inc. increased its holdings in shares of Perrigo by 9.7% in the third quarter. Voisard Asset Management Group Inc. now owns 5,100 shares of the company’s stock valued at $134,000 after purchasing an additional 450 shares in the last quarter. Atria Investments Inc acquired a new stake in shares of Perrigo in the third quarter valued at approximately $208,000. Finally, CWM LLC increased its holdings in shares of Perrigo by 877.0% in the second quarter. CWM LLC now owns 8,197 shares of the company’s stock valued at $210,000 after purchasing an additional 7,358 shares in the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.
Perrigo Trading Down 0.5 %
Shares of NYSE PRGO opened at $27.45 on Friday. The company’s fifty day moving average is $26.52 and its 200-day moving average is $26.97. The stock has a market cap of $3.74 billion, a price-to-earnings ratio of -23.46 and a beta of 0.52. Perrigo Company plc has a twelve month low of $23.89 and a twelve month high of $34.60. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94.
Perrigo Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Friday, November 29th will be given a $0.276 dividend. The ex-dividend date is Friday, November 29th. This represents a $1.10 annualized dividend and a yield of 4.02%. Perrigo’s dividend payout ratio is currently -94.02%.
Insider Activity at Perrigo
In related news, Director Jeffrey B. Kindler sold 17,598 shares of the business’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $28.27, for a total value of $497,495.46. Following the sale, the director now directly owns 5,409 shares of the company’s stock, valued at approximately $152,912.43. The trade was a 76.49 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.70% of the stock is currently owned by insiders.
Analyst Ratings Changes
A number of brokerages recently weighed in on PRGO. Jefferies Financial Group reissued a “hold” rating and issued a $30.00 price target (down previously from $50.00) on shares of Perrigo in a report on Monday, September 23rd. StockNews.com raised shares of Perrigo from a “hold” rating to a “buy” rating in a report on Thursday, November 7th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $42.00 target price on shares of Perrigo in a report on Monday, September 30th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $37.00.
Check Out Our Latest Research Report on PRGO
Perrigo Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Read More
- Five stocks we like better than Perrigo
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- P/E Ratio Calculation: How to Assess Stocks
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.